Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Glioblastoma Multiforme (GBM) Therapeutics
1.2 Key Market Segments
1.2.1 Glioblastoma Multiforme (GBM) Therapeutics Segment by Type
1.2.2 Glioblastoma Multiforme (GBM) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Glioblastoma Multiforme (GBM) Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Glioblastoma Multiforme (GBM) Therapeutics Market Competitive Landscape
3.1 Global Glioblastoma Multiforme (GBM) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Glioblastoma Multiforme (GBM) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Glioblastoma Multiforme (GBM) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Glioblastoma Multiforme (GBM) Therapeutics Sales Sites, Area Served, Product Type
3.6 Glioblastoma Multiforme (GBM) Therapeutics Market Competitive Situation and Trends
3.6.1 Glioblastoma Multiforme (GBM) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Glioblastoma Multiforme (GBM) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Glioblastoma Multiforme (GBM) Therapeutics Industry Chain Analysis
4.1 Glioblastoma Multiforme (GBM) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Glioblastoma Multiforme (GBM) Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Glioblastoma Multiforme (GBM) Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Glioblastoma Multiforme (GBM) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Glioblastoma Multiforme (GBM) Therapeutics Price by Type (2019-2024)
7 Glioblastoma Multiforme (GBM) Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Glioblastoma Multiforme (GBM) Therapeutics Sales Growth Rate by Application (2019-2024)
8 Glioblastoma Multiforme (GBM) Therapeutics Market Segmentation by Region
8.1 Global Glioblastoma Multiforme (GBM) Therapeutics Sales by Region
8.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Sales by Region
8.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Glioblastoma Multiforme (GBM) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Glioblastoma Multiforme (GBM) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Glioblastoma Multiforme (GBM) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Glioblastoma Multiforme (GBM) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Glioblastoma Multiforme (GBM) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.1.2 Merck Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.1.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Glioblastoma Multiforme (GBM) Therapeutics SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Roche
9.2.1 Roche Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.2.2 Roche Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.2.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Glioblastoma Multiforme (GBM) Therapeutics SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Arbor Pharmaceuticals
9.3.1 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.3.2 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.3.4 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics SWOT Analysis
9.3.5 Arbor Pharmaceuticals Business Overview
9.3.6 Arbor Pharmaceuticals Recent Developments
9.4 Pfizer
9.4.1 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.4.2 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.4.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 AbbVie
9.5.1 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.5.2 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.5.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.5.4 AbbVie Business Overview
9.5.5 AbbVie Recent Developments
9.6 Amgen
9.6.1 Amgen Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.6.2 Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.6.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Bristol-Myers Squibb
9.7.1 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.7.2 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.7.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.7.4 Bristol-Myers Squibb Business Overview
9.7.5 Bristol-Myers Squibb Recent Developments
9.8 Sun Pharmaceuticals
9.8.1 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.8.2 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.8.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.8.4 Sun Pharmaceuticals Business Overview
9.8.5 Sun Pharmaceuticals Recent Developments
9.9 Teva Pharmaceutical
9.9.1 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.9.2 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.9.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.9.4 Teva Pharmaceutical Business Overview
9.9.5 Teva Pharmaceutical Recent Developments
9.10 Emcure Pharmaceuticals
9.10.1 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Basic Information
9.10.2 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Overview
9.10.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Market Performance
9.10.4 Emcure Pharmaceuticals Business Overview
9.10.5 Emcure Pharmaceuticals Recent Developments
10 Glioblastoma Multiforme (GBM) Therapeutics Market Forecast by Region
10.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast
10.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Region
10.2.4 South America Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Glioblastoma Multiforme (GBM) Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Glioblastoma Multiforme (GBM) Therapeutics by Type (2025-2030)
11.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Glioblastoma Multiforme (GBM) Therapeutics by Type (2025-2030)
11.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Glioblastoma Multiforme (GBM) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings